• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4640408)   Today's Articles (188)   Subscriber (50354)
For: Furst DE, Clements PJ, Wong WK, Mayes MD, Wigley F, White B, Weisman M, Barr W, Moreland L, Martin R, Medsger TA, Steen V, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Peter JB, Seibold JR. Effects of the American College of Rheumatology systemic sclerosis trial guidelines on the nature of systemic sclerosis patients entering a clinical trial. Rheumatology (Oxford) 2001;40:615-22. [PMID: 11426017 DOI: 10.1093/rheumatology/40.6.615] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
Number Cited by Other Article(s)
1
Costa M, Jorge I, Martin P, Nisihara R, Skare T. Males and females with scleroderma: A comparative study in a Brazilian sample. Arch Rheumatol 2023;38:542-548. [PMID: 38125061 PMCID: PMC10728735 DOI: 10.46497/archrheumatol.2023.10011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2022] [Accepted: 12/30/2022] [Indexed: 12/23/2023]  Open
2
Figueiredo FP, Aires GD, Nisihara R, Skare TL. Sleep Disturbance in Scleroderma. J Clin Rheumatol 2021;27:S242-S245. [PMID: 32568947 DOI: 10.1097/rhu.0000000000001437] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
3
Anti-cyclic citrullinated peptide antibodies in scleroderma patients. Clin Rheumatol 2012;31:877-80. [DOI: 10.1007/s10067-011-1930-z] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2011] [Revised: 10/18/2011] [Accepted: 12/22/2011] [Indexed: 02/02/2023]
4
Liver autoantibodies in patients with scleroderma. Clin Rheumatol 2010;30:129-32. [PMID: 20931345 DOI: 10.1007/s10067-010-1586-0] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2010] [Revised: 08/13/2010] [Accepted: 09/26/2010] [Indexed: 10/19/2022]
5
Amjadi S, Maranian P, Furst DE, Clements PJ, Wong WK, Postlethwaite AE, Khanna PP, Khanna D. Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials. ACTA ACUST UNITED AC 2009;60:2490-8. [PMID: 19644851 DOI: 10.1002/art.24681] [Citation(s) in RCA: 94] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
6
Miniati I, Valentini G, Cerinic MM. Cyclophosphamide in systemic sclerosis: still in search of a 'real life' scenario. Arthritis Res Ther 2009;11:103. [PMID: 19226435 PMCID: PMC2688227 DOI: 10.1186/ar2576] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]  Open
7
Savas N, Dagli U, Ertugrul E, Kuran S, Sahin B. Autoantibody profile in systemic sclerosis as a marker for esophageal and other organ involvement in Turkish populations. Dig Dis Sci 2007;52:3081-6. [PMID: 17393310 DOI: 10.1007/s10620-007-9809-1] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/27/2006] [Accepted: 02/13/2007] [Indexed: 12/09/2022]
8
Denton CP, Black CM. Targeted therapy comes of age in scleroderma. Trends Immunol 2005;26:596-602. [PMID: 16168710 DOI: 10.1016/j.it.2005.09.002] [Citation(s) in RCA: 49] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2005] [Revised: 08/16/2005] [Accepted: 09/06/2005] [Indexed: 12/18/2022]
9
Seibold JR. Clinical trials: types, design, and end-points. Curr Opin Rheumatol 2001;13:512-5. [PMID: 11698730 DOI: 10.1097/00002281-200111000-00011] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA